GEVO CEO Paul Bloom Sells $50K of Stock
CEO Paul Bloom sold 35,189 shares of Gevo in a planned move.
Reviewed by automated data checks against the source filing. How we make and check alerts
Paul Bloom, CEO at Gevo, Inc. ($GEVO), sold 35,189 shares at an average price of $1.43, worth about $50,320.27, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $GEVO is up 1.4% after 1 week, up 6.4% after 1 month and down 16.4% to date (from the $1.40 close on Jun 12, 2026).
GEVO
Gevo, Inc.
Key Points
- Paul Bloom, CEO of Gevo, Inc., sold 35,189 shares valued at $50,320.27 on June 12, 2026, at an average price of $1.43 per share.
- Gevo's stock trades near $1.43 with a market cap of $348 million, a forward P/E of 143, and a 52-week range of $1.12 to $2.97.
- Other insiders also sold shares on the same date, and analyst firms including UBS and Northland Capital Markets have set price targets ranging from $2.00 to $14.00.
Get $GEVO trade alerts by text
We text you when insiders, Congress or big funds trade $GEVO. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Gevo, Inc. alert may contain errors. Disclosures
Paul Bloom, the CEO of Gevo, Inc., executed a planned sale of 35,189 shares on June 12, 2026. The transaction was valued at $50,320.27, with each share sold at an average price of $1.43. This sale is part of a pre-arranged trading plan.
Insider Buying and Selling at Gevo, Inc.
On June 12, 2026, several insiders at Gevo, Inc. sold shares in planned transactions. Alongside CEO Paul Bloom, Chief Marketing Officer Andrew Shafer sold 9,443 shares, CFO Oluwagbemileke Yusuf sold 63,028 shares, and President & COO Christopher Ryan sold 35,196 shares. These transactions were executed at prices around $1.40 to $1.43 per share.
Other Institutional Activity in Gevo, Inc.
Several institutional investors have adjusted their holdings in Gevo. BlackRock, Inc. reduced its stake by 49,779 shares, holding 17,321,015 shares valued at approximately $47.3 million. Vanguard Capital Management LLC acquired 10,133,640 shares, ending with the same number of shares worth about $27.7 million. State Street Corp increased its position by 641,544 shares to a total of 9,065,919 shares, valued at $24.7 million. Geode Capital Management, LLC also added 219,461 shares, totaling 5,881,507 shares valued at $16.1 million.
Gevo, Inc. Stock Down 8.9%
Shares of NasdaqCM:GEVO are trading around $1.43. Gevo, Inc. has a market capitalization of approximately $348 million and a forward P/E ratio of 143. The stock's beta is 0.991, indicating relatively stable price movements compared to the market. Gevo's 52-week low is $1.12, and its high is $2.97. The stock's 50-day moving average is $1.80, while the 200-day moving average is $2.02. The company maintains a strong current ratio of 4.31 and a quick ratio of 3.34, with a debt-to-equity ratio of 37.44.
Analysts Set New Price Targets
On May 22, 2026, UBS maintained a 'hold' rating for Gevo, setting a price target of $2.00. Earlier, Northland Capital Markets maintained a 'buy' rating with a target of $3.50 on April 16, 2026. The consensus among analysts is a 'buy' recommendation, with a mean target price of $5.33 based on four analyst opinions.
About Gevo, Inc.
Gevo, Inc. is a company focused on carbon abatement, headquartered in Englewood, Colorado. It operates in the basic materials sector, specifically within the specialty chemicals industry. The company is involved in producing sustainable aviation fuel and other renewable fuels, as well as chemicals and materials. Gevo employs 151 people and is led by CEO Dr. Paul D. Bloom. It also engages in the development and operation of projects that convert methane emissions into renewable natural gas.
Bottom Line
Insider sales at Gevo, Inc. reflect pre-planned transactions, with CEO Paul Bloom among those executing sales. Investors closely watch such insider activities, though they may not necessarily indicate future stock performance. Gevo's stock is currently trading near its 52-week low, and analysts have varied price targets, reflecting different outlooks on the company's potential.
Related Filing Alerts
Source: Paul Bloom's Form 4 filing on $GEVO (Jun 12, 2026). Find the original filing: GEVO Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts